epiberberine has been researched along with scriptaid in 1 studies
| Studies (epiberberine) | Trials (epiberberine) | Recent Studies (post-2010) (epiberberine) | Studies (scriptaid) | Trials (scriptaid) | Recent Studies (post-2010) (scriptaid) |
|---|---|---|---|---|---|
| 49 | 0 | 37 | 101 | 1 | 73 |
| Protein | Taxonomy | epiberberine (IC50) | scriptaid (IC50) |
|---|---|---|---|
| Histone deacetylase 8 | Schistosoma mansoni | 1.77 | |
| Histone deacetylase 3 | Homo sapiens (human) | 0.3274 | |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 4.4 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.43 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.8318 | |
| Histone deacetylase 7 | Homo sapiens (human) | 1.33 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.63 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.43 | |
| Histone deacetylase 11 | Homo sapiens (human) | 2.83 | |
| Histone deacetylase 8 | Homo sapiens (human) | 2.038 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.1194 | |
| Histone deacetylase 9 | Homo sapiens (human) | 0.63 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.43 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.1884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
1 other study(ies) available for epiberberine and scriptaid
| Article | Year |
|---|---|
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |